A population study on blood-brain barrier function in 85-year-olds: Relation to Alzheimer's disease and vascular dementia

    loading  Checking for direct PDF access through Ovid

Abstract

Article abstract

We investigated blood-brain barrier (BBB) function in relation to Alzheimer's disease (AD) and vascular dementia (VAD) in the very elderly. Sixty-five 85-year-old persons from a population-based sample were followed for 3 years; 29 were demented at age 85 (13 with AD, 14 with VAD, and 2 with other dementias), 7 developed dementia during follow-up, and 29 remained nondemented. CSF/serum albumin ratio was used as as a measure of BBB function. Dementia was defined according to the DSM-III-R, AD according to the NINCDS-ADRDA criteria, and VAD according to the NINDS-Association Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN) criteria. Mean CSF/serum albumin ratio was higher in all dementias (8.5± 4.3; p = 0.007) and in the subtypes AD (8.9 ± 5.3; p = 0.046) and VAD (8.7 ± 3.5; p= 0.002) than in nondemented individuals (versus 6.5 ± 2.0), but it was not related to dementia severity. Nondemented women at age 85 (n = 3) who developed dementia during the follow-up had a higher CSF/serum albumin ratio than those not developing dementia (10.4 ± 2.0 versus 6.0 ± 1.9; p = 0.007). Nondemented individuals lacking the apolipoprotein E ε3 allele (n = 4) had a higher CSF/serum albumin ratio (9.3 ± 0.8 versus 6.6 ± 2.1; p = 0.029) than other individuals. A relative BBB dysfunction is associated with both AD and VAD among very elderly individuals. This finding is possibly found early in the disease before the onset of clinical dementia.

Related Topics

    loading  Loading Related Articles